UDCA Response Score
Cross-source consensus on UDCA Response Score from 1 sources and 3 claims.
1 sources · 3 claims
Uses
Benefits
Other
Highlighted claims
- OPERA uses URS to identify participants at enhanced risk of not achieving biochemical remission on UDCA alone. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
- The UDCA Response Score combines pretreatment clinical inputs to estimate risk of failing to reach biochemical remission on UDCA. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
- Baseline risk stratification with URS is presented as one of OPERA's main strengths. — Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid